Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Beximco Pharmaceuticals Limited Sponsored GDR RegS ( (GB:BXP) ) has issued an update.
Beximco Pharmaceuticals Ltd has announced a change of its company name to Beximco Pharmaceuticals PLC, effective from November 5, 2025, on the AIM Market of the London Stock Exchange. This change, approved by shareholders and the Registrar of Joint Stock Companies and Firms in Bangladesh, does not affect the company’s TIDM, ISIN, SEDOL, or LEI numbers, and all existing legal instruments and share certificates remain valid. The name change reflects the company’s ongoing growth and its commitment to maintaining its strong market presence.
More about Beximco Pharmaceuticals Limited Sponsored GDR RegS
Beximco Pharmaceuticals Ltd is a leading manufacturer and exporter of generic medicines based in Bangladesh, established in 1976. The company offers a wide range of pharmaceutical products including tablets, capsules, and injectables, and provides contract manufacturing services for multinational and global generic companies. Its manufacturing facilities are certified by regulatory authorities in the USA, Europe, Australia, Canada, GCC, and Latin America, and it operates in over 50 countries with more than 6000 employees.
Average Trading Volume: 44,996
Technical Sentiment Signal: Buy
For detailed information about BXP stock, go to TipRanks’ Stock Analysis page.